Switching patients with stable schizophrenia or schizoaffective disorder from olanzapine to risperidone long-acting injectable.
about
Comparison between two generic questionnaires to assess satisfaction with medication in chronic diseases.Adverse effects associated with second-generation antipsychotic long-acting injection treatment: a comprehensive systematic review.The characteristics and health needs of pregnant women with schizophrenia compared with bipolar disorder and affective psychosesSchizophrenia-spectrum patients treated with long-acting injectable risperidone in real-life clinical settings: functional recovery in remitted versus stable, non-remitted patients (the EVeREST prospective observational cohort study).Switching from oral atypical antipsychotic monotherapy to paliperidone palmitate once-monthly in non-acute patients with schizophrenia: A prospective, open-label, interventional studySystematic Literature Review of the Methods Used to Compare Newer Second-Generation Agents for the Management of Schizophrenia: A focus on Health Technology Assessment.Effects of aripiprazole once-monthly on symptoms of schizophrenia in patients switched from oral antipsychotics.The effects of switching from oral to LAI antipsychotic treatment on subjective experience of schizophrenic and schizoaffective patients: Preliminary results.Switching long acting antipsychotic medications to aripiprazole long acting once-a-month: expert consensus by a panel of Italian and Spanish psychiatrists.
P2860
Q34598490-79F5B557-33D2-4494-8480-32A53A6A5A86Q34775426-9345C675-6C1C-4F05-977D-D65A1076A156Q35521365-13E81F31-063A-49E3-9855-A0FFF69B067AQ35895582-567A456E-CEAE-4537-B12A-900859DDB09EQ37547469-CCBB3C6B-FF6C-4A6F-933E-218406A50D8EQ38473914-277078F3-D437-41BD-AD20-6CDE027C1C53Q47958975-CC0CE4AC-FED8-418B-86E3-BED64E55F6DFQ48059462-86A281D5-BFF5-44F4-937B-72572FC012C7Q50541514-16315192-8A67-47B4-B061-32E8EE134BC0
P2860
Switching patients with stable schizophrenia or schizoaffective disorder from olanzapine to risperidone long-acting injectable.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Switching patients with stable ...... ridone long-acting injectable.
@en
type
label
Switching patients with stable ...... ridone long-acting injectable.
@en
prefLabel
Switching patients with stable ...... ridone long-acting injectable.
@en
P2093
P2860
P1476
Switching patients with stable ...... ridone long-acting injectable.
@en
P2093
Andreas Schreiner
Fernanda Rosa
Pierre Thomas
Tarek Sherif
P2860
P304
P356
10.2165/11599080-000000000-00000
P577
2012-04-01T00:00:00Z